.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Farmers Insurance
Mallinckrodt
Medtronic
Citi
Accenture
Chubb
Harvard Business School
Novartis

Generated: June 24, 2017

DrugPatentWatch Database Preview

LENTE Drug Profile

« Back to Dashboard

What is the patent landscape for Lente, and when can generic versions of Lente launch?

Lente is a drug marketed by Novo Nordisk Inc and Lilly and is included in four NDAs.

The generic ingredient in LENTE is insulin zinc susp beef. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin zinc susp beef profile page.

Summary for Tradename: LENTE

Patents:0
Applicants:2
NDAs:4
Clinical Trials: see list4
Drug Prices:see details
DailyMed Link:LENTE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
LENTE
insulin zinc susp purified pork
INJECTABLE;INJECTION018383-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Novo Nordisk Inc
LENTE INSULIN
insulin zinc susp beef
INJECTABLE;INJECTION017998-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
LENTE ILETIN II
insulin zinc susp purified beef
INJECTABLE;INJECTION018477-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
LENTE ILETIN II (PORK)
insulin zinc susp purified pork
INJECTABLE;INJECTION018347-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Novo Nordisk Inc
LENTE INSULIN
insulin zinc susp beef
INJECTABLE;INJECTION017998-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Harvard Business School
Accenture
Fish and Richardson
Dow
QuintilesIMS
Federal Trade Commission
Deloitte
UBS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot